_michael_scholl Profile Banner
Michael Schöll Profile
Michael Schöll

@_michael_scholl

Followers
2K
Following
3K
Media
50
Statuses
612

Professor at the Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, and Principal Research Fellow at the UCL DRC

Gothenburg, Sweden
Joined June 2017
Don't wanna be here? Send us removal request.
@_michael_scholl
Michael Schöll
4 years
So excited and honoured to be elected to the Young Academy of Sweden! I am very grateful for this opportunity to actively impact research politics and work conditions for young research leaders.
@Ungaakademin
Sveriges unga akademi
4 years
Fantastiska forskare från ett brett spektrum av discipliner: 8 nya ledamöter välkomnas till Sveriges unga akademi: @umeauniversitet @lunduniversity @uppsalauni @SCAS_Uppsala @goteborgsuni @karolinskainst
Tweet media one
22
1
116
@_michael_scholl
Michael Schöll
11 days
RT @alzforum: Largest-ever tau-PET studies confirm ties between tangles and cognitive decline. ApoE4 carriers and women get tangles earlies….
0
8
0
@_michael_scholl
Michael Schöll
1 month
RT @NicholasAshton: NPTX2 is emerging as a key neurodegeneration biomarker, but measurement tools are limited. We developed a low-volume, a….
0
9
0
@_michael_scholl
Michael Schöll
1 month
Our most important paper, out now! A massive international collaboration, led by @AlexisMoscoso9, featuring over 6500 visually assessed tau PET scans covering the #Alzheimers spectrum!. Thank you very much to the numerous contributors and collaborators who made this gem possible.
@JAMA_current
JAMA
1 month
Tau PET positivity is detectable in a small but nonnegligible proportion of individuals in the preclinical stages of #Alzheimer disease, with increasing frequency in symptomatic stages of the disease.
1
13
51
@_michael_scholl
Michael Schöll
1 month
RT @JAMA_current: Tau PET positivity is detectable in a small but nonnegligible proportion of individuals in the preclinical stages of #Alz….
0
4
0
@_michael_scholl
Michael Schöll
3 months
RT @MolNeuro: 'Cautions on utilizing plasma GFAP level as a #biomarker for reactive #astrocytes in #neurodegenerative diseases'. Wongu Youn….
Tweet card summary image
molecularneurodegeneration.biomedcentral.com
0
5
0
@_michael_scholl
Michael Schöll
3 months
RT @EmmaCoomans: So excited and honored to be invited to present the opening plenary at #AIC2025 this year in Toronto! 🧠 . 🙏 I would be ver….
0
12
0
@_michael_scholl
Michael Schöll
3 months
RT @neurochem4: Happy to share our latest work published today in @NatureComms .We leverage #ai enhanced microscopy guided #maldi @imaging_….
0
4
0
@_michael_scholl
Michael Schöll
5 months
RT @MasudHusain: Why academia is sleepwalking into self-destruction. My editorial @Brain1878 If you agree with the sentiments please RT. I….
0
198
0
@_michael_scholl
Michael Schöll
5 months
RT @davecash75: Congratulations to @WillCoath on passing his PhD viva exploring amyloid and tau PET in the Insight 1946 birth cohort! Many….
0
5
0
@_michael_scholl
Michael Schöll
6 months
RT @nfranzme: Incredibly happy and proud to share our newest work in @ScienceTM showing that Aβ promotes neuronal hyperconnectivity, thereb….
Tweet card summary image
science.org
Aβ induces neuronal hyperconnectivity, which promotes tau spreading from temporal lobe epicenters to connected brain regions in Alzheimer’s disease.
0
24
0
@_michael_scholl
Michael Schöll
6 months
Always my favourite post at the beginning of the year:. Registration for our course “Biomarkers for neurodegenerative diseases” is now open!. This year’s edition takes place at @UCLIoN in central London on May 12-16.
1
19
58
@_michael_scholl
Michael Schöll
6 months
Happy to share this narrative review paper on the clinical use of blood-based biomarkers for #Alzheimer’s disease, hopefully this can serve as a resource to anyone seeking advice on implementation. #endalz.
1
8
37
@_michael_scholl
Michael Schöll
8 months
RT @UCLBrainScience: We're delighted that 22 of our academics have been identified in Clarivate’s annual ‘Highly Cited Researchers List’ 20….
0
5
0
@_michael_scholl
Michael Schöll
8 months
Third time’s a charm! 🎈. Very honoured to be ranked among the world’s most influential researchers according to Clarivate Web of Science three years in a row now!. Praise belongs to my team, our collaborators and our study participants!.
Tweet card summary image
clarivate.com
The Highly Cited Researchers 2024 list identifies and celebrates individuals who have demonstrated significant and broad influence in their fields of research. Through rigorous selection criteria and...
3
0
28
@_michael_scholl
Michael Schöll
8 months
RT @Laura_Sofia_S: Hej hej!🇸🇪.Happy to share that I’ve started a new postdoc with @_michael_scholl on the #REAL-AD study! Grateful for join….
0
2
0
@_michael_scholl
Michael Schöll
8 months
Please join us in Gothenburg on January 30 for a symposium on recent advances in the cognitive assessment of neurodegenerative diseases! We are excited to host a truly excellent panel of lecturers!. Please register free of charge by email to ann-sophie.hilkert@gu.se. #ENDALZ
Tweet media one
3
6
33
@_michael_scholl
Michael Schöll
9 months
Very excited to have you onboard! 🎉.
@EllenSingletonn
Ellen Singleton
9 months
Excited to have officially joined the #REAL #AD team at @_michael_scholl's group this week alongside @Laura_Sofia_S 🙌 and grateful for the great kick-off last week at #CTAD24 where #REAL #ADs first results were presented 🙏⭐️👇 @EndAlz @goteborgsuni
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
1
26